Kyrok lands €3.1M to bring AI to pharma supply chains
The founders, Lukas Bierfreund, Daniel Hofinger, © Kyrok
Berlin-based startup Kyrok has secured €3.1 million in pre-seed funding to build what it calls the first AI operating system for supply chain teams in the European pharma and chemicals mid-market. The round is led by Vienna-based VC Speedinvest, with participation from Arve Capital, the family office of pharmaceutical packaging market leader Sanner, and a roster of industry heavyweights including ex-SAP CPO Dr. Marcell Vollmer and the founders of enterprise AI startup Langdock. The company announced the news via press release.
The problem Kyrok is targeting is very real: a significant portion of German pharma and chemicals production still runs on SAP R/3 systems from the 1990s, supplemented by Excel spreadsheets and the institutional knowledge of staff approaching retirement. Germany's pharma and chemicals sector is the country's third-largest industrial branch, representing over 560,000 jobs — more than 90% at mid-size companies. Supply chain pressure is mounting too, with nearly 560 drug shortage notifications filed with Germany's Federal Institute for Drugs and Medical Devices (BfArM) at the end of 2025 alone.
Kyrok's approach is to layer an AI application on top of existing ERP systems — no migration needed. Industry-specific AI agents guide teams through their workflows in a modern interface, handling routine tasks while keeping final decisions with the human in the loop. Early pilot results are promising: Kyrok captures more than 80% of complex orders error-free, with significant time savings on routine tasks.
Founded in 2025 by Daniel Hofinger and Lukas Bierfreund, Kyrok will use the fresh capital to expand its platform and grow its Berlin team to meet rising demand.
Thinking about launching a business, setting up premises, or creating partnerships in Berlin?
We invite you to contact us.
Our team is ready to help you with our free consultation services.